Brucella Infection among Prison Inmates in Borno State, Nigeria
Keywords:
Seroprevalence, Brucellosis, Inmates, NigeriaAbstract
Aim: The study was conducted to determine the seroprevalence of brucellosis among prison inmates in three senatorial zones, Bama, Biu and Maiduguri prisons, in Borno State, Nigeria. A total of 214 Blood samples were collected from January 2014 – July 2014.
Materials and Methods: Blood samples were aseptically collected from two hundred and fourteen (214) prison inmates. The sera obtained from the blood samples were screened for Brucella antibodies by Rose Bengal Plate Test (RBPT) and Microtitre Serum Agglutination Test (MSAT).
Results: The overall seroprevalence among the prison inmates tested in all the three senatorial zones were 26(12.1%), and 22(10.2%) for RBPT and MSAT respectively, of which 8(10.8%) and 6(8.1%) were from Bama, 12(14.2%) and 12(14.2%) were from Biu, while 6(10.7) and 4(7.1%) for RBPT and MSAT were from Maiduguri respectively. There was no significant statistical difference (P>0.05) in the seroprevalence based on location among the prison inmates in the state. There was no significant statistical difference (P>0.05) in the seroprevalence based on age of the prison inmates in the state, though the study showed higher seroprevalence among individuals above40 years followed by those above 20 years and less among individual up to 20 years.
Conclusions: Brucella infection was found in all the three senatorial zones in Borno State. There is the need to control the disease in the prisons. Further studies are recommended in all the prisons in Nigeria. The study should involve isolation of the organism and determining their bio-types, in prison inmates and other people in the country.
References
1. Krikic-Dautovic S, Mehanic S, Ferhatovic M, Cavaljuga S. Brucellosis epidemiological and clinical aspects (Is brucel-losis a major public health problem in Bosnia and Herze-govina?). Bosn J Basic Med Sci 2006;6:11–5.
2. Nusrat H. Disease specific diagnostic method and lym-phokines in human brucellosis. PhD Thesis, University of Karachi, Pakistan 2004.
3. Nimri LF (Diagnosis of recent and relapsed cases of human brucellosis by PCR assay. Infect Dis 2003; 28: 3–5.
4. Abu-Shaqra QM.. Epidemiological aspects of brucellosis in Jordan. Eur J Epidemiol 2000; 16: 581–584.
5. Fosgate GT, Carpenter TE, Chomel BB, Case JT, Debess EE, Reilly KF. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis 2002; 8: 672–678.
6. Cooper CW. Risk factors in transmission of brucellosis from animals to humans in Saudi Arabia Transactions of the Royal Society of Tropical Medicine and Hygiene 1992; 86: 206–209.
7. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos V. The new global map of human brucellosis. Lan-cet Infect 2006; 6: 91–99.
8. Corbel MJ. Brucellosis: An overview, Emerg Infec Dis 1997; 3: 213–221.
9. Hoover DL, Friedlander AM. Brucellosis. Textbook of Mil-itary Medicine Medical Aspects of Chemical and Biologi-cal Warfare 2005; 513–521.
10. Mantur BM, Mangalgi SS, Mulimani MS. Brucella melitensis - a sexually transmissible agent Lancet 1996; 347.
11. Wood E. Brucellosis as a hazart of blood transfusion. Br Med J 1995; 1: 27–28.
12. Young EJ, Mandell GL, Douglas RC, Bennett JE, Dolin R. Brucella species. Principles and Practice of infectious Dis-eases Philadelphia: Churchill Livingstone 2001; 2386–2393.
13. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucello-sis. New England J Med 2005; 352: 2325–2336.
14. Falade S. Brucella agglutinating antibodies in the sera of persons dwelling in Ibadan and the surrounding districts. J Nig Vet Med Ass 1974; 3: 21–23.
15. Adekolu EO. A serological Survey of human brucellosis in Kanji Lake population of Nig Trop Vet 1989; 7: 141–148.
16. Ocholi RA, Kalejaiye JO, Okewole PA. Brucellosis in Nige-ria: A Review. Trop Vet 1993; 11:15–26.
17. Njoku AJ. Brucellosis or Malaria. The Nig J Parasitol 1995; 16:75-78.
18. Atsanda NN, Agbede SA. Seroprevalence of Brucellosis Antibiotics in Cattle herds and Human beings in some parts of Adamawa state of Nigeria. Sokoto J Vet Sci 2001; 3: 34–38.
19. Geographical Survey of Nigeria (GSN) (1994). The survey of the Nigerian’s climatic date. 6: 3. Cited in Dura MM. Physical, Environment and Development: a study of Borno Region. In: Ogunica OI, Daura MM, Balami D (eds). Envi-ronment and Development issues in Sub-Saharan Africa, Seminar services, Faculty of Social Sciences, University of Maiduguri 2001; 35–47.
20. Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the Brucellosis Laboratory. 1st Ede. Institut National de la Recherche Agronomique, Paris. 1988; 21–145.
21. Baba MM, Sarkindared SE, Brisibe F. Serological evidence of brucellosis among predisposed patients with pyrexia of unknown origin in the north eastern Nigeria. Central Eu-ropean J Public Health 2001; 3(9): 158–161.
22. Junaidu AU, Oboegbulem SI, Daneji AI, Garba HS, Salihu MD, Gulumbe ML, Alhassan K, Philips OA. High Brucella infection in patients with febrile illness in Sokoto, Nigeria: A study in malaria and typhoid endemic region, Res Opin Anim Vet Sci 2011; 1(S): S5–S8.
23. Junaidu AU, Oboebulem SI, Salihu MD. Seroprevalence of Brucellosis in Prison Farm in Sokoto, Nigeria. Asian J Epid 2008; 1(1): 24–28.
24. Young EJ. Brucella species In: Principles and practice of Infectious disease, Eds. Mandell GI, Bennet JE, Dolin R. Philadelphia: Churchill, Livingstone 2000; 2386–2393.
25. Ahmed MO, Elmeshri SE, Abuzweda AR, Blauo M, Abou-zeed YM, Ibrahim A, Salem H, Alzwam F, Abid S, Elfahem A, Elrais A. Seroprevalence of brucellosis in ani-mals and human populations in the western mountains re-gion in Libya. Euro Surveill 2010; 10: 15(30)
26. Ndyabahinduka DG, Chu IH. Brucellosis in Uganda Int J zoonoses 1984; 11: 59–64.
27. Karabay O, Serin E, Tamer A, Gokdogan F, Alpteker H, Ozcan A, Gunduz H. Hepatitis B carriage and Brucella se-roprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiological study. Turk J Gas-troenterol 2004; 15: 11–13.
28. Al-Sekait MA. Seroepidemiological survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med 1999; 19: 219–222.
29. Li S, Cui H, Yuan Q, Wu J, Wadhwa A, Eda S, Jiang H. AC electrokinetics- enhanced capacitive immunosensor for point-of-care serodiagnosis of infectious diseases. Biosens. Bioelectron 2014; 51: 437–443.
30. Cui H, Li S,Yuan Q,Wadhwa A, Eda S, Chambers M, Ash-ford R, Jiang H, Wu J. An AC electrokinetic impedance immunosensor for rapid detection of tuberculosis. Analyst 2013; 138: 7188–7196.
31. Wadhwa A, Hickling GJ, Eda S. Opportunities for im-proved serodiagnosis of human tuberculosis, bovine tuber-culosis, and paratuberculosis. Vet Med Int 2012a; 1–13.
32. Wadhwa A, Foote RS, Shaw RW, Eda S. Bead-based mi-crofluidic immunoassay for diagnosis of Johne's disease. J Immunol Methods 2012b; 382: 196–202.
33. Liu X, Yang K, Wadhwa A, Eda S, Li S, Wu J. Develop-ment of an AC electrokineticsbased immunoassay system for on-site serodiagnosis of infectious diseases. Sensor Ac-tuat A-Phys., 2011; 171: 406-413.
Downloads
Published
How to Cite
Issue
Section
License
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
